INCLUSION BODY MYOSITIS
Clinical trials for INCLUSION BODY MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new INCLUSION BODY MYOSITIS trials appear
Sign up with your email to follow new studies for INCLUSION BODY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare Muscle-Wasting disease
Disease control CompletedThis study tested a new drug called ABC008 in 272 adults with inclusion body myositis, a rare muscle disease that causes weakness. The goal was to see if the drug is safe and can help slow the disease. Participants received either the drug or a placebo, and their muscle function …
Matched conditions: INCLUSION BODY MYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Stem cell shot may slow rare muscle disease
Symptom relief CompletedThis study tested whether injecting stem cells into the forearm and thigh is safe for people with Inclusion Body Myositis, a rare muscle-weakening disease. Nine adults took part, each receiving injections on one side of the body. The main goal was to check for side effects, with …
Matched conditions: INCLUSION BODY MYOSITIS
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Military mystery: why do some soldiers develop rare muscle disease?
Knowledge-focused CompletedThis study looked at why some military personnel develop myositis, a rare disease where the immune system attacks muscle tissue, causing weakness and pain. Researchers compared 37 people—some with myositis and some healthy—using questionnaires and blood samples to find possible e…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC